CXCL12 and cardiovascular disorder: In vivo, administration of the bifunctional protein leads to enhanced recruitment of BMCs, increased capillary density, reduced infarct size, and preserved cardiac function.[32,33] On the other hand, our group could recently show, that high platelet SDF-1 levels might alter outcomes in patients with cardiovascular disease in a negative way (unpublished).